8,655 Studies Reviewed. 86.9% Found Biological Effects. The Evidence is Clear.
Shield Your Body
Whole Body / General

Brain Sci 10(5):266, 2020

Bioeffects Seen

Authors not listed · 2020

Share:

Controlled 40 Hz electromagnetic field exposure increased apoptosis-related genes in stroke patients, suggesting potential therapeutic applications distinct from chronic exposure concerns.

Plain English Summary

Summary written for general audiences

Researchers studied 48 post-stroke patients receiving rehabilitation, with half exposed to extremely low frequency electromagnetic fields (40 Hz, 5 mT). The ELF-EMF group showed increased expression of genes associated with programmed cell death (apoptosis), which researchers suggest might promote brain plasticity and recovery. This preliminary finding challenges conventional thinking about EMF effects on neural recovery.

Why This Matters

This study presents an intriguing paradox in EMF research. While most EMF health concerns focus on harmful effects, these researchers found that controlled ELF-EMF exposure (40 Hz at 5 milliTesla) increased pro-apoptotic gene expression in stroke patients, which they theorize could support brain recovery. The exposure parameters here are significant: 5 mT is substantially higher than typical household exposures (which range from 0.1 to 1 mT near appliances), delivered in a controlled therapeutic setting.

What this means for you: This study doesn't suggest EMF is universally beneficial. The science demonstrates that biological responses to EMF are complex and context-dependent. In acute stroke, apoptosis damages healthy tissue. But 3-4 weeks post-stroke, controlled apoptosis might help clear damaged cells and support neuroplasticity. This reinforces what independent researchers have long argued: we need to understand EMF's biological mechanisms, not dismiss them. The reality is that therapeutic applications don't negate chronic exposure concerns. Controlled medical use under supervision differs fundamentally from continuous, involuntary exposure in daily life.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2020). Brain Sci 10(5):266, 2020.
Show BibTeX
@article{brain_sci_105266_2020_ce3997,
  author = {Unknown},
  title = {Brain Sci 10(5):266, 2020},
  year = {2020},
  doi = {10.3390/brainsci10050266},
  
}
DOI: 10.3390/brainsci10050266PubMed: 32455904

Quick Questions About This Study

This preliminary study found that 40 Hz ELF-EMF exposure (5 mT) increased pro-apoptotic gene expression in post-stroke patients 3-4 weeks after their stroke. Researchers theorize this might support brain plasticity and recovery, but they acknowledge further research is needed to clarify the actual therapeutic benefit and mechanism.
The ELF-EMF exposure significantly increased expression of BAX, CASP8, TNFα, and TP53—all genes involved in programmed cell death (apoptosis). However, BCL-2, an anti-apoptotic gene, remained unchanged. This pattern suggests activation of specific cell death pathways that researchers believe might support brain recovery post-stroke.
Researchers used a 5 milliTesla (mT) field strength, which is considerably higher than typical household EMF exposures (0.1-1 mT near appliances). This was combined with standard rehabilitation therapy and delivered in controlled medical sessions, not continuous exposure. The specific frequency was 40 Hz.
The timing matters critically. During acute stroke, apoptosis causes additional brain damage and correlates with worse outcomes. However, this study investigated the subacute phase (3-4 weeks post-stroke), when researchers theorize controlled apoptosis might help clear damaged cells and activate neuroplasticity, potentially supporting recovery rather than causing harm.
No. This study examined highly controlled therapeutic exposure in a specific medical context (post-stroke rehabilitation). Potential therapeutic applications under medical supervision don't address or negate concerns about chronic, involuntary EMF exposure from wireless devices and infrastructure in daily life. The biological contexts and exposure parameters are fundamentally different.